Why is OpenAI dropping Scale AI as data provider?
How will Microsoft’s planned job cuts impact sales?
What caused Honda’s major US car recall?
Why did Meta offer $100 million to poach AI staff?
How will rising Middle East tensions affect oil prices?
What does Nippon Steel’s US Steel acquisition mean?
Why is the Fed holding interest rates steady now?
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
benzinga.com/analyst-stock-ratings/downgrades/25/06/46003836/eli-lillys-1-3-billion-verve-deal-signals-confidence-in-gene-editing-space-analy
On Tuesday, Eli Lilly And Co (NYSE:LLY) agreed to acquire Verve Therapeutics, Inc. (NASDAQ:VERV), a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.
Lilly offered to purchase Verve for $10.50 per share in cash, an aggregate of approximately…
This story appeared on benzinga.com, 2025-06-18 17:59:21.